A Japanese historical cohort study reconstructed progression-free survival of 3.5 months in 75 atezolizumab-treated lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results